Hsu, Cynthia L.
Wang, Yanhan
Duan, Yi
Chu, Huikuan
Hartmann, Phillipp
Llorente, Cristina
Zhou, Rongrong
Schnabl, Bernd http://orcid.org/0000-0002-6281-825X
Funding for this research was provided by:
Foundation for the National Institutes of Health (T32 DK007202, K12 HD85036, R01 AA24726, R37 AA020703, U01 AA026939, U01 AA026939-04S1, P30 DK120515, P50 AA011999)
National Institute of Environmental Health Sciences (KL2TR001444)
American Association for the Study of Liver Diseases (PNC22-159963)
U.S. Department of Veterans Affairs (BX004594)
Biocodex Microbiota Foundation
Article History
Received: 16 August 2022
Accepted: 30 January 2023
First Online: 20 February 2023
Declarations
:
: B.S. has been consulting for Ambys Medicines, Ferring Research Institute, Gelesis, HOST Therabiomics, Intercept Pharmaceuticals, Mabwell Therapeutics, Patara Pharmaceuticals and Takeda. B.S.’s institution UC San Diego has received research support from Axial Biotherapeutics, BiomX, CymaBay Therapeutics, NGM Biopharmaceuticals, Prodigy Biotech and Synlogic Operating Company. B.S. is founder of Nterica Bio. UC San Diego has filed several patents with Y.D., C.L. and B.S. as inventors related to this work.